• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[幽门螺杆菌感染与消化性溃疡的三联治疗10天。4周及1年后的治疗状态]

[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].

作者信息

Berstad A, Berstad K, Hatlebakk J G, Wilhelmsen I, Nysaeter G, Bang C J, Hausken T, Nesje L B, Hjartholm A S, Hundal O

机构信息

Gastroenterologisk seksjon, Haukeland Sykehus, Bergen.

出版信息

Tidsskr Nor Laegeforen. 1994 Sep 10;114(21):2477-9.

PMID:7940447
Abstract

We treated 143 Helicobacter pylori positive ulcer patients (duodenal ulcer 81, gastric ulcer 24, pyloric ulcer nine, previous duodenal ulcer 27, others two) with a ten days regimen of bismuth subnitrate, oxytetracycline and metronidazole. Four weeks after cessation of treatment the 14C-urea breath test showed that the infection was eradicated in 133 out of 140 patients (95%). The ulcer had healed in 129 (97%) of the H. pylori negative patients. Status at one year after treatment showed that 121 (98.4%) of 123 patients who had become H. pylori negative had remained negative. None of the H. pylori negative patients experienced ulcer relapse. The results show that the treatment is effective and that the rate of recurrence of H. pylori during the first year is very low.

摘要

我们采用次硝酸铋、土霉素和甲硝唑的十天疗程治疗了143例幽门螺杆菌阳性溃疡患者(十二指肠溃疡81例、胃溃疡24例、幽门溃疡9例、既往十二指肠溃疡27例、其他2例)。治疗结束四周后,14C-尿素呼气试验显示,140例患者中有133例(95%)感染被根除。幽门螺杆菌阴性的患者中有129例(97%)溃疡已愈合。治疗一年后的情况显示,123例转为幽门螺杆菌阴性的患者中有121例(98.4%)仍为阴性。幽门螺杆菌阴性的患者均未出现溃疡复发。结果表明该治疗有效,且第一年幽门螺杆菌的复发率非常低。

相似文献

1
[10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].[幽门螺杆菌感染与消化性溃疡的三联治疗10天。4周及1年后的治疗状态]
Tidsskr Nor Laegeforen. 1994 Sep 10;114(21):2477-9.
2
Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.对242例幽门螺杆菌感染根除后一年的消化性溃疡病患者进行随访。
Hepatogastroenterology. 1995 Sep-Oct;42(5):655-9.
3
Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.使用次硝酸铋、土霉素和甲硝唑根除消化性溃疡病患者的幽门螺杆菌。
Hepatogastroenterology. 1994 Feb;41(1):43-7.
4
Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).铋剂联合疗法治疗幽门螺杆菌相关性消化性溃疡疾病(甲硝唑用于根除,雷尼替丁用于止痛)。
Am J Gastroenterol. 1996 May;91(5):935-41.
5
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.简化的10天铋剂三联疗法治疗幽门螺杆菌感染:甲硝唑耐药率高的人群临床实践经验
Am J Gastroenterol. 1998 Feb;93(2):212-6. doi: 10.1111/j.1572-0241.1998.00212.x.
6
Bismuth therapy for Helicobacter pylori infection. A review of five years experience at a university hospital in Norway.铋剂治疗幽门螺杆菌感染:挪威一家大学医院五年经验回顾
J Physiol Pharmacol. 1996 Mar;47(1):31-49.
7
[Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Tidsskr Nor Laegeforen. 1992 Oct 20;112(25):3197-9.
8
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.出血性溃疡的抗幽门螺杆菌治疗:比较2天与7天铋剂四联疗法的随机对照试验
Am J Gastroenterol. 1997 Mar;92(3):438-41.
9
Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.在日本人群中采用奥美拉唑、克拉霉素和替硝唑(OCT方案)根除幽门螺杆菌后的长期随访。
Helicobacter. 2005 Oct;10(5):379-84. doi: 10.1111/j.1523-5378.2005.00344.x.
10
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.基于奥美拉唑的三联疗法与基于铋剂的三联疗法治疗幽门螺杆菌感染的比较:一项前瞻性随机1年随访研究。
Am J Gastroenterol. 1997 Apr;92(4):653-8.

引用本文的文献

1
Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori.与检测幽门螺杆菌对甲硝唑体外耐药性的试验缺乏标准化相关的风险。
Eur J Clin Microbiol Infect Dis. 1996 Jun;15(6):484-8. doi: 10.1007/BF01691316.